From Mind To Market - Boehringer Ingelheim

2
Value through Innovation
Many of the world’s leading research-oriented
biopharmaceutical companies and top ranking
pharmaceutical organizations have discovered
the value of partnership with Boehringer
Ingelheim. We have proved time and time again
that we have the experience and the capability to
convert promising product ideas into commer cial
reality on a global scale. Throughout our history,
our expertise in development and manufacturing,
worldwide registration and marketing has achieved
significant patient benefit.
The Corporate Division Biopharmaceuticals at
Boehringer Ingelheim, is a process oriented
group. Together with its biotechnology units in
Vienna and Biberach it provides state-of-the-art
technology for developing and manufacturing
biopharmaceuticals. Bold, dynamic, and trustworthy,
our company provides the ideal conditions
for joint ventures to succeed. As a pioneer
in biopharmaceuticals, we can demonstrate
profound understanding of this exciting and
fast-moving field.
The Boehringer Ingelheim approach is reflected
in our mission statement: “Value through
Innovation”. This is more than simply sharing
financial risk. Our partners can rely on our
creativity to find cost-effective solutions to their
process development needs. They can accelerate
time to clinic and market, bring early return on
Prof. Dr. Dr. h.c. Rolf G. Werner
Boehringer Ingelheim GmbH
Corporate Division Biopharmaceuticals
investment and maximize patent life span, while
focusing on high quality and product safety. We
also recognize the importance of flexible, fully
integrated teamwork, and the need to tailor our
services and processes to the individual needs
of each company we partner. We can help at any
or every stage of the process, providing solutions
that may range from early development to largescale
manufacturing and worldwide marketing
agreements.
Our strategic partnerships are based on a team
approach. Working with our partners we can
provide the most efficient process development,
deliver goods at competitive prices, gain regulatory
approval worldwide and achieve global
market supply. As a fully integrated pharmaceutical
company we are also offering creative
solutions for joint product development through
clinical phases and worldwide marketing & sales
options. Being responsible for the strategic
orientation and the worldwide bio business at
Boehringer Ingelheim, I invite the biopharmaceutical
community to work with us and discover
that development and manufacturing don’t have
to be obstacles for new therapies on their way
“From Mind To Market.”